Thanks to earlier detection, gene testing, and new treatments, people with lung cancer are living longer, healthier lives. Deaths from the most common type of lung cancer fell by 6.3% every year from 2013 through 2016, according to a study published in August 2020.
If you’ve been diagnosed with lung cancer, it’s important to think about steps you can take in partnership with your doctor to manage your care and maintain a healthy lifestyle so you can live well for as long as possible. One type of tool that can help: mobile apps.
“Apps are like your own personal mini-medical record,” says Cedric “Jamie” Rutland, MD, a pulmonary and critical care doctor in California and a national spokesperson for the American Lung Association. “They can take all the information about you, your condition, your treatment, and other important topics and organize it in a way that’s easily accessible.”
Metastatic Colorectal Cancer Market Size Anticipated to Expand at a CAGR of 2.6% (2020-30) in the 7MM in the coming decade - DelveInsight
Metastatic Colorectal Cancer Market Report lays down a comprehensive view of the mCRC market trends covering key pharmaceutical companies in the market, upcoming as well as Metastatic Colorectal Cancer marketed therapies, unmet needs, prevailing constraints and the factors driving the Metastatic Colorectal Cancer market size growth.
The report covers the Metastatic Colorectal Cancer Epidemiological analysis focusing on the mCRC incidence and diagnosed patient pool segmented on the basis of several factors, as well as the upcoming trends of the mCRC epidemiology that is going to affect the overall patient pool and the Metastatic Colorectal Cancer Market outlook.
COVID Vaccine in Patients With Cancer: NCCN Outlines Priorities medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Ohio State joins nationwide effort to resume cancer screening, treatment The James COLUMBUS The Ohio State University Comprehensive Cancer Center – Arthur G.
Jams Cancer Hospital and Richard J. Solove Research Institute (OSUCCC –
James) is teaming up with the National Comprehensive Cancer Network®
(NCCN®), the American Cancer Society (ACS) and other leading cancer
organizations across the country to endorse the resumption of cancer
screening and treatment during the ongoing COVID-19 pandemic.
The
coalition of 76 organizations has released an open letter reminding the
public that cancer still poses a major threat to people’s health. They
note that acting as soon as is safely possible to obtain preventative
Credit: Kim Ratliff, Augusta University Photographer
AUGUSTA, Ga. (Feb. 1, 2020) - A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
The 523-gene panel, developed by San Diego-based biotech company Illumina, which includes all genes known to potentially cause cancer, can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML, the investigators report in the journal
PLOS ONE.
Identifying more genetic mutations in an individual s cancer also enables more targeted treatment for that patient, they say. That includes finding mutations not previously associated with their cancer type, which opens the door to using drugs targeting those mutations that have traditionally been used against other cancers.